Old Web
English
Sign In
Acemap
>
authorDetail
>
Jinchun Yan
Jinchun Yan
Princeton University
Medicine
Cytotoxic T cell
in patient
Gastroesophageal Junction Adenocarcinoma
Antibody-drug conjugate
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase 1 multicenter, dose expansion study of ARX788 as monotherapy in patients with HER2-positive advanced gastric and gastroesophageal junction adenocarcinoma (ACE-Gastric-01).
2021
Journal of Clinical Oncology
Yang Zhang
Miao Zhen Qiu
Jufeng Wang
Yanqiao Zhang
Xianglin Yuan
Tao Zhang
Jinchun Yan
Gaozhun Xiong
Yanping Ji
Xuejun Liang
Gang Xia
Rui Hua Xu
Show All
Source
Cite
Save
Citations (0)
Safety and unique pharmacokinetic profile of ARX788, a site-specific ADC, in heavily pretreated patients with HER2-overexpresing solid tumors: Results from two phase 1 clinical trials.
2021
Journal of Clinical Oncology
Sara A. Hurvitz
Haeseong Park
Sophia Frentzas
Catherine Shannon
Katharine Cuff
Richard Eek
George Thomas Budd
Amelia McCartney
Joyce OShaughnessy
Janice M. Lu
Jian Zhang
Dongmei Ji
Weina Shen
Matt Li
Jinchun Yan
Gang Xia
Yanping Ji
Sulan Yao
Gaozhun Xiong
Xichun Hu
Show All
Source
Cite
Save
Citations (0)
1